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Abstract. It is well known that ionizing radiation can induce biological eﬀects at diﬀerent levels, from DNA,
chromosomes and cells up to tissues, organs and entire organisms. Theoretical models and Monte Carlo codes,
especially those based on radiation track structure, can be of great help to elucidate the underlying mechanisms
and to perform reliable predictions where data are lacking. In this work we will present and discuss a mechanistic
ab initio model and a Monte Carlo code able to simulate the induction of chromosome aberrations (CAs) in human
cells. This endpoint is particularly relevant, since some aberration types can lead to cell death, while others can lead
to cell conversion to malignancy. The model is based on the hypothesis that only clustered lesions (CLs) of the DNA
double-helix can evolve into aberrations. Simulated dose-response curves for CAs induced by diﬀerent radiation
types (including heavy ions) will be shown, together with applications to cancer risk estimation and biodosimetry. In
this framework, we will also discuss examples of medical applications – including astronauts’ exposure to space
radiation – obtained with the FLUKA code, also taking into account the role of nuclear interactions.
1 Introduction
Human beings can be exposed to ionizing radiation from
diﬀerent sources such as the Earth natural background,
medical diagnostics or treatments and occupational exposure.
However, the involved dose and dose rates can be very
diﬀerent: the total Earth background is about 2–3 mSv/yr,
whereas for example an abdomen CT requires doses of the
order of 10 mSv. Tumor treatments involve much higher
doses (about 50 Gy in “standard” treatments, which generally
consist of 20–25 fractions). However, it has to be taken into
account that it’s only the tumor which receives such high
doses, though also normal tissues surrounding the tumor
volume can receive (unwanted) small doses.
Both for the Earth background and for medical exposure,
low-LET (Linear Energy Transfer) radiation, typically X
rays, is involved. However, it is worth mentioning that an
increasing number of radiotherapy facilities are now making
use of protons or heavier ions, typically Carbon [1]. The
latter are currently used at NIRS in Chiba, Japan, and at
GSI in Darmstadt, Germany. New Carbon facilities are under
construction in Pavia, Italy, in Heidelberg, Germany, and in
other Japanese locations. Both protons and heavier ions are
characterized by a localization of energy deposition in the
so-called “Bragg peak” region, that can allow for an increase
of Tumor Control Probability (TCP), particularly for certain
radioresistant tumors, with low Normal Tissue Complication
Probability (NTCP). While ions such as Argon have shown
unacceptable complications to normal tissues, Carbon beams
are particularly suitable because their Relative Biological
Eﬀectiveness is suﬃciently low (approximately 1, as for
protons) in the plateau before the Bragg peak, whereas it is
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higher (up to 3–4 and even more, to be compared with the
typical 1.1 value of proton beams) in the region of the peak.
Another scenario where high LET radiation is involved is
the exposure of astronauts to space radiation. The spectrum
of Galactic Cosmic Rays, to which astronauts are exposed
continuously, consists of about 87% protons, 12% He ions and
1% heavier ions in fluence. Although the dose rate is relatively
low (of the order of 1 mSv/day in free space), radiation
can represent a serious threat for the crewmembers of long-
term missions. This is especially true for missions in deep
space outside the Geomagnetic field, that is the case of lunar
missions and possible travels to Mars. The exposure scenario
in space is further complicated by “Solar Particle Events”
(SPEs), which are occasional but almost unpredictable injec-
tions of high fluxes (up to more than 1010 particles · cm−2 in
few hours, to be compared with 4 particles · cm−2·s−1 for GCR)
of charged particles coming from the Sun, mainly protons
with energies below a few hundred MeV. In this context,
after a general overview on the eﬀects of ionizing radiation
on biological targets (sect. 2), in section 3 we will present
examples of calculations related to the characterization of
therapeutic proton beams and the estimation of space radiation
doses for astronauts.
To characterize the action of ionizing radiation at the
organ/organsm level, it is necessary to understand the mech-
anisms underlying radiobiological damage at cellular and
subcellular level. Therefore, in section 4 we will focus on
the mechanisms underlying the induction of chromosome
aberrations (CAs), which are a particularly relevant endpoint
because they are correlated both with cell death and with cell
conversion to malignancy, implying that CAs can influence
the “fate” of the cells. More specifically, we will present a
mechanistic model and Monte Carlo code able to simulate the
induction of the main aberration types following exposure of
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human cells to diﬀerent radiation types including ions such as
Carbon and Iron, which are of interest for hadrontherapy and
space radiation protection, respectively.
2 A brief overview on the effects of ionizing
radiation on biological targets
The action of ionizing radiation in biological targets is a
stochastic, multi-step process involving several orders of mag-
nitude, both in the space scale and in the time scale. Primary
energy deposition, which can be considered completed at
10−15 seconds after irradiation (“physical stage”), produces a
spatial distribution of ionized and excited molecules. Although
the DNA occupies only ≈2% of the cell nucleus volume, it is
the most important target for ionizing radiation. Also energy
deposition in the surrounding water plays a significant role,
since during the so-called “prechemical stage” (from 10−15 to
10−12 s after irradiation) the dissociation of ionized and excited
H2O molecules gives rise to free radicals (e.g., the OH radical)
that can attack the double helix constituents and produce DNA
damage.
DNA damage, either produced by direct energy deposition
in the double-helix atoms (“direct damage”) or produced
by free radical attack (“indirect damage”), is processed by
specific repair enzymes. The oxygen level in the environment
is an important parameter, since O2 can link damaged sites
preventing repair and thus acting as a “damage fixer”. This
has implications for radiation therapy, since hypoxic tumors
result to be particularly radio-resistant. In case of incorrect
DNA repair, the initial damage can evolve within a few
hours into endpoints such as gene mutations and chromosome
aberrations, which in turn may lead to cell death, or cell
conversion to malignancy and possibly cancer. While cell
death and conversion to malignancy can be detected in vitro
after a few days or weeks, cancer is characterized by long
latency times of the order of several years.
To have a quantitative idea of the yields of the var-
ious damage types, one may consider that a mammalian
cell nucleus irradiated with 1 Gy of gamma rays will be
aﬀected, on average, by about 100,000 ionizations (2,000 in
the DNA), 1,000 DNA single-strand breaks (ssb), 40 double-
strand breaks (dsb), 1 chromosome aberration (or even less)
and 10−5 gene-specific mutations. The probability of cancer
development is far less than 10−5.
Since the double-helix diameter is about 2 nanometers,
the knowledge of radiation track structure at the nm level is
an essential prerequisite for understanding the mechanisms
underlying the processes of interest. The expression “track
structure” refers to a set of information including, for each
energy deposition event (typically a ionization or excitation),
spatial coordinates of the event, event type and amount of
deposited energy. The higher-order organization characteriz-
ing mammalian DNA is another important modulating factor.
Each DNA molecule winds around globular proteins (“his-
tones”) to form structures called nucleosomes, which in turn
are packed to form a 30-nm diameter chromatin fiber. The
fiber is organized as a succession of loops that, for most of
the cell cycle duration, are localized within distinct domains
called chromosome territories, with linear dimensions of the
order of ≈1 µm. During the last decade, when the advances
in confocal microscopy allowed more detailed investigation
of nuclear architecture, it became clear that DNA damage
processing mainly occurs in small channels separating neigh-
bouring domains. Therefore, when dealing with chromosome
aberration induction, the spatial distribution of the initial
energy depositions needs to be considered not only at the
nanometer scale (i.e., the double helix level), but also at the
micrometer scale (i.e., the chromosome level).
3 Effects at the level of organs and organism:
examples of calculations of interest for
radiotherapy and space radiation protection
In previous works aimed to the characterization of therapeutic
proton beams, calculations have been performed on physical
and “biological” doses along the plateau and the Spread-Out
Bragg Peak (SOBP) of the 72 MeV proton beam used for
the treatment of ocular tumors at the Paul Sherrer Institut
(PSI) in Switzerland [2]. Such calculations have been carried
out with FLUKA, a multi-purpose Monte Carlo code able
to deal with transport and interaction of electromagnetic and
hadronic particles over a wide energy range in any material
[3–5]. The “biological dose” has been defined as the average
number of “Complex Lesions” (CLs) per cell. CLs, which
are clustered breaks of the DNA double helix, have been
operatively defined and calculated basing on radiation track-
structure simulations at the nm level [6]. Importantly, the
beam Relative Biological Eﬀectiveness (RBE) was found to
be 1.2 along most of the SOBP (except for an increase in
the peak distal part), consistent with the constant value of
1.1 adopted in therapeutic practice with protons. While the
absorbed dose was roughly constant with depth throughout
the entire SOBP, the calculated profile of “biological” dose
showed a sharp increase at the distal part of the SOBP due
to the presence of protons with low energy and thus high LET
and biological eﬀectiveness. In order to quantify the role of nu-
clear interactions, the contributions from the various radiation
field components have been calculated separately. Secondary
particles produced by nuclear interaction accounted for less
than 4% of the total absorbed dose in most of the SOBP,
and disappeared in its distal part. The relative contribution
of nuclear reaction products to the biological dose was larger
with respect to the absorbed dose, reaching values of about
12% in the proximal part of the SOBP. The method described
above was then extended to the characterization of a “virtual”
160 MeV proton beam [7]. These results confirm the reliability
of the RBE value of 1.1 generally adopted in proton therapy.
Concerning space radiation protection, in the framework
of the FLUKA collaboration, calculations have been per-
formed on astronaut doses following exposure to space radi-
ation under diﬀerent shielding conditions. These results have
been obtained coupling FLUKA with two anthropomorphic
phantoms, i.e., a mathematical model based on combinatorial
geometry [8] and a “voxel” model constructed starting from
whole-body CT data [9]. Both phantoms have been inserted
into an Al cylindrical shell of variable thickness, i.e., 1 and
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Table 1. Organ-averaged dose equivalents (in Sv) calculated for the
August 1972 SPE for diﬀerent values of Al shielding thickness (in
g.cm−2).
Al shield Skin Eye Red Bone Marrow
1 13.31 6.89 1.80
2 7.25 4.90 1.32
5 2.23 1.60 0.62
10 0.62 0.56 0.25
Table 2. GCR annual eﬀective doses (in Sv) calculated for for
diﬀerent values of Al shielding thickness (in g cm−2).
Al shield Male dose Female dose
1 0.47 0.44
2 0.46 0.41
3 0.43 0.41
5 0.42 0.41
2 g · cm−2 (nominal spacesuit and lightly shielded spacecraft),
5 g · cm−2 (nominal spacecraft) and 10 g · cm−2 (storm shelter
to be used in case of SPE). Organ-averaged dose equivalent
values, as well as eﬀective doses, have been calculated ac-
cording to ICRP 60 [10]. Table 1 shows organ-averaged dose
equivalents (for skin, eyes and red bone marrow, which are the
reference organs for radiation protection against deterministic
eﬀects) calculated by simulating exposure to the August 1972
SPE. As expected, all dose types decrease dramatically by
increasing the shielding. For each considered thickness of
the Al shielding, the dose due to the products of nuclear
reactions of primary protons with the shield and the human
body has been calculated separately. Although the role of
nuclear reaction products is not negligible (especially for
heavy shielding with respect to light shielding, due to target
fragmentation), primary protons play a major role. According
to these calculations, in case of a solar event similar to the
August 1972 SPE an Al storm shelter of 10 g/cm2 Al would
be suﬃcient to respect the NCRP limits for 30-days missions
in Low Earth Orbit, which are 1.5, 1.0 and 0.25 for skin, eye
lenses and Blood Forming Organs, respectively [11]. However,
since these limits refer to Low Earth Orbit missions within the
Geomagnetic field, numerical comparisons with deep space
scenarios should be taken with caution, considering such
numbers as mere guidelines while waiting for the introduction
of new reference values specific for deep space.
Table 2 shows annual eﬀective doses for GCR exposure
at solar minimum (in Sv). According to these results, a
hypothetical 2-years mission in deep space (typical duration of
a possible mission to Mars) under solar minimum conditions
would allow to respect the NCRP career limits [11] for males
who are at least 35-years-old (limit: ≥1 Sv) and females of
at least 45 (limit: ≥0.9 Sv). Again, comparisons with these
limits need to be considered with caution due to the reasons
mentioned above.
As expected because of the GCR high energy, GCR doses
do not decrease significantly by increasing the Al shielding.
As for the August 1972 SPE, for each Al thickness value
the contributions from primary ions and nuclear interac-
tion products have been calculated separately. Similarly to
what obtained for SPEs, the contribution of nuclear reaction
Table 3. Calculated GCR doses (in mGy/year) in a water phantom
placed inside a cylindrical habitat under 3 metres regolith.
Total dose 7.2
Primary ions 0.0
Secondary particles 7.2
neutrons 6.7
products was found to increase with the Al shield thickness.
However, in comparison to SPEs, in the case of GCR the
relative contribution of nuclear interaction products was much
higher, being roughly the same as that of the primary ions.
Following GCR dose calculations in deep space, FLUKA
has been recently applied to analogous calculations for the
Moon [12]. More specifically, a cylindrical habitat was sim-
ulated, placed in a cavity under the Moon surface. Outside
the habitat, the cavity was filled with regolith, and the habitat
itself was covered with a 3 metres thick regolith layer. A water
phantom was placed in the habitat.
Preliminary calculations for GCR irradiation showed that
the total dose in the phantom was 7.2 mGy/year. As expected,
this dose was entirely due to secondary particles (including
neutrons). Interestingly, neutrons alone delivered a dose of
6.7 mGy/year, as reported in table 3.
The cosmic ray simulation tools are courtesy of the
FLUKA Collaboration [3–5,13,14].
4 Induction of chromosome aberrations
by ionizing radiation
It is now widely accepted that chromosome aberrations are due
to breakage of the DNA double helix and subsequent incorrect
rejoining of the involved DNA fragments. However, various
aspects of the underlying mechanisms – such as the role of
clustered DNA damage and of chromosome organization
within the cell nucleus – need further clarification. In this
framework, theoretical models and Monte Carlo codes
can be of great help to clarify the mechanisms leading to
initial energy deposition by radiation to the formation of
chromosome aberrations.
The main assumption of our model [15–17] consists of
considering chromosome aberrations as the “evolution” of
clustered DNA breaks or “Complex Lesions” (CLs), which
have been operationally defined as “at least two breaks in each
of the two DNA strands within 30 base-pairs” [6]. Regardless
of the definition, which is necessary to get quantitative simu-
lation results, the key point is that these lesions are clustered,
and thus severe and diﬃcult to be processed by the cell repair
machinery.
This assumption also relies on the fact that the dependence
of CLs on radiation quality reflects that shown by data on
the induction of gene mutations and cell death, whereas
non-clustered double-strand breaks show a much weaker de-
pendence on the radiation type and energy. To model CA
induction, each CL is assumed to produce two independent
chromosome free ends. Only free ends induced in neighbour-
ing chromosomes or in the same chromosome are allowed to
join and give rise to aberrations, reflecting the experimental
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Fig. 1. Preliminary example of simulated human fibroblast cell
nucleus with its 46 chromosome territories (see the text for further
details).
evidence that DNA repair takes place within the channels
separating the various chromosome “territories”, which are
basically non-overlapping intra-nuclear regions occupied by
a single chromosome.
The current version of the model deals with human lym-
phocyte nuclei, which are modelled as 3-µm radius spheres;
the implementation of human fibroblast nuclei is in progress,
and a preliminary example is shown in figure 1. Both for
lymphocytes and for fibroblasts, the 46 chromosome territories
are described as (irregular) intra-nuclear domains with volume
proportional to the chromosome DNA content. Each territory
consists of the union of small adjacent cubes. Repetition of
chromosome territory construction with diﬀerent chromosome
positions provides diﬀerent configurations for cell nuclei in the
G0 phase of the cell cycle.
The yield (i.e., average number, taken from “event-by-
event” radiation track structure simulations at the nm level)
of induced CL · Gy−1 · cell−1 is the starting point for
dose-response simulations. While for photons the lesions are
randomly distributed in the cell nucleus, for light ions they
are located along straight lines representing the cell nucleus
traversals.
For a given dose D (in Gy), the average number of cell
nucleus traversals n is calculated by n = Dπr2/(0.16LET),
where the LET is expressed in keV/µm, r (in µm) is the cell
nucleus radius and 0.16 is a factor coming from the conversion
between Joules and eV. An actual number is extracted from
a Poisson distribution. For each cell nucleus traversal, a
random extraction of the point where the particle enters the
nucleus provides the traversal length, being the direction fixed
(irradiation with parallel beam).
The average number of CLs per unit length along a cell
nucleus traversal is CL/µm = 0.16 · CL Gy−1 · cell−1 · LET ·
V−1, where V is the cell nucleus volume in µm3. For each
nucleus traversal, a Poisson distribution provides an actual
number of lesions. The comparison of the CL positions with
the positions of the (centres of the) boxes constituting each
chromosome territory allows the association of each lesion to
a chromosome.
Specific background (i.e., prior to irradiation) yields for
diﬀerent aberration types – typically 0.001 dicentrics/cell and
0.005 translocations/cell – can be included. Both Giemsa
staining (all chromosomes painted with the same colour) and
FISH selective painting can be simulated; small fragments,
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Fig. 2. Dose-response for simple exchanges (average no. per 100
cells) induced by Fe ions (upper panel) and C ions (lower panel).
The lines are model predictions, whereas the points are experimental
data taken from the literature [19].
i.e., with size of about 10 Mbp (Mega base-pairs) or less,
are generally not scored since they can hardly be detected in
experiments. The simulation of CL induction and rejoining
for a suﬃciently high number of times provides statistically
significant aberration yields. The repetition of the process for
diﬀerent dose values allows to obtain dose-response curves for
the main aberration types, directly comparable with experi-
mental data.
In previous work the model has been tested for gamma
rays, protons and He ions by comparing simulated dose-
response curves with experimental data available in the lit-
erature, without performing any fit a posteriori. The good
agreement between model predictions and experimental data
for the induction of diﬀerent aberration types allowed for
model validation regarding both the adopted assumptions and
the simulation techniques. Furthermore, the model has been
applied to the induction of Chronic Myeloid Leukaemia [18]
and to the estimation of chromosome aberrations observed
in lymphocytes of astronauts following long-term missions
onboard the Mir station and the International Space Station,
on the basis of simulated gamma-ray dose responses weighted
by the space radiation quality factor [17].
The extension of the model to heavy ions is in progress:
as a first approach, a fraction of the DNA lesions induced
by a heavy ion are “shifted” radially to model the eﬀects of
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the so-called “delta rays”, which play a significant role in
determining the features of heavy-particle tracks.
An example of preliminary results is reported in figure 2,
which shows dose response curves for simple exchanges
(i.e. dicentrics plus translocations) induced by 1 GeV/n
Fe ions (LET=147 keV/micron) and 290 Mev/n C ions
(LET = 13.3 keV/micron). The lines represent model predic-
tions, whereas the points are experimental data taken from the
literature [19].
It is of interest for low-dose applications to report that,
according to our simulations, while a single cell nucleus
traversal by a 1 GeV/n proton or He ion resulted not to give
rise to aberration yields higher than the background levels
(due to their high velocity and low charge, and thus low
LET), a single 1 GeV/n Iron traversal was found to induce
chromosome aberration yields of the order of 0.26/cell both
for dicentrics and translocations.
Also in progress is the implementation of chromosome
aberration transmission to the cell progeny and, on the other
side, of cell killing, basing on the fact that cells carrying
specific aberrations (typically dicentrics) have a significant
probability of failing to duplicate.
5 Conclusions
In the present work, an overview was given about where
humans can be exposed to radiation and about the main
eﬀects of radiation on biological targets. Some examples were
reported on radiation eﬀects at organ/organism level, i.e.,
on the characterization of therapeutic proton beams and the
calculation of astronauts doses.
Concerning the radiation eﬀects at cellular level, a model
and a Monte Carlo code was presented, able to simulate
chromosome aberration induction by diﬀerent radiation types.
The model is based on the assumption that clustered DNA
breaks play a fundamental role in the processes leading from
energy deposition to the formation of chromosome aberra-
tions. The good agreement of the model with experimental
data provided a validation of both the assumptions and the
simulation techniques. Furthermore, applications of the model
to biodosimetry and cancer induction were shown.
Together, these results outline the importance of nuclear
data need not only for hadrontherapy and space research, but,
more generally, for all those scenarios which imply exposure
to mixed fields.
This work was partially supported by the European Community (EC
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